Physician profile
Brian D Tracy
NPI 1356308266
$2,019.31
in general payments reported to CMS, 2019-2025
14 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $126 · 2021: $256 · 2022: $243 · 2023: $392 · 2024: $449 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $579.87 | 2023-2025 | Infuse, Miebo, Biotrue One Day |
| Coopervision INC. | $403.46 | 2020-2025 | Cvi Contact Lens, Synergeyes Contact Lens, Paragon Crt |
| Tarsus Pharmaceuticals, INC. | $250.74 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $154.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $135.79 | 2020-2023 | |
| Lombart Brothers, INC. | $119.50 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $82.43 | 2019-2025 | |
| Biotissue Holdings INC. | $68.97 | 2020-2024 | |
| Alcon Vision LLC | $58.39 | 2025 | Precision7, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $50.33 | 2022 | |
| Eyevance Pharmaceuticals LLC | $42.05 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.04 | 2019-2021 | |
| Allergan, INC. | $23.41 | 2022 | |
| Oyster Point Pharma, INC. | $17.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.